Reviewed by Dr. Mark A. Cappel, MD, Double Board-Certified Dermatologist and Dermatopathologist, Founder of Dermagnify | Ponte Vedra Beach, FL
If you have started a GLP-1 medication like Ozempic or Wegovy and noticed changes in your facial appearance, including hollowness under the eyes, sagging skin around the jowls, or a deflated look, you are not imagining it. This phenomenon, widely referred to as Ozempic face, is one of the most common aesthetic side effects reported by patients on GLP-1 receptor agonists, and dermatologists across the country are seeing it with increasing frequency.
The good news? It is treatable. At Dermagnify in Ponte Vedra Beach, Florida, Dr. Mark A. Cappel, MD, a double board-certified dermatologist and dermatopathologist trained at Mayo Clinic, works with patients throughout Northeast Florida, including Jacksonville and St. Augustine, to develop personalized non-surgical plans for restoring facial volume and skin quality after GLP-1-related changes.
What Is Ozempic Face?
"Ozempic face" is an informal term used to describe the facial aging that can occur as a result of rapid weight loss while taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). The term gained traction in mainstream media as more patients and clinicians began connecting the dots between accelerated fat loss and accelerated facial aging.
When weight is lost quickly, whether through GLP-1 medications, diet, or surgery, the face loses subcutaneous fat that acts as a structural scaffold beneath the skin. This leads to a constellation of changes that can make patients look significantly older, even when their body is in better shape than ever.
Common signs of Ozempic face include:
- Hollowing beneath the eyes and temples
- Deepening of nasolabial folds (smile lines)
- Jowling or sagging along the jawline
- Loss of cheek volume and overall facial fullness
- Increased skin laxity and crepey texture
- A gaunt or deflated appearance
Importantly, Ozempic face is not caused by the medication itself damaging the skin. It is a consequence of rapid fat loss from any area of the body, including the face. The skin, which may have already been experiencing collagen decline due to age, is simply unable to contract quickly enough to accommodate the change in volume.
Why Does GLP-1 Weight Loss Affect the Face?
Understanding the mechanism behind Ozempic face helps explain why targeted treatment, not simply time, is required to address it.
1. Fat Loss Is Not Selective
GLP-1 medications promote systemic fat loss by suppressing appetite and slowing gastric emptying. The body draws on fat reserves from all areas, including the face. Facial fat is organized into compartments that provide three-dimensional structure and youthful contour. When these compartments deflate, the overlying skin loses its support.
2. Collagen Declines With Age and Accelerates With Rapid Weight Loss
After the age of 25, collagen production declines by approximately 1% per year. Rapid weight loss compounds this by creating mechanical stress on the skin. It must stretch and contract in response to volume changes faster than collagen can regenerate. The result is laxity, fine lines, and an aged appearance that can seem disproportionate to a patient's overall health.
3. The Skin Cannot Contract Fast Enough
Unlike abdominal or thigh skin, which has greater surface area to redistribute, facial skin is tightly adherent to underlying structures. When the fat compartments beneath it shrink, the skin does not simply snap back. Patients who lose weight gradually over many months fare better than those who lose significant weight rapidly, which is exactly the mechanism GLP-1 medications are designed to achieve.
Can Ozempic Face Be Prevented?
Prevention is not always possible, particularly for patients who lose a significant amount of weight. However, several strategies can reduce the severity of facial changes during GLP-1 treatment.
- Lose weight at a moderate pace when medically appropriate. Discuss dosing strategy with your prescribing physician.
- Maintain adequate protein intake to support collagen synthesis and lean muscle mass.
- Stay well-hydrated. Dehydration amplifies the appearance of skin laxity.
- Begin a medical-grade skincare regimen early, including retinoids, peptides, and antioxidants that support collagen production.
- Consider preventive cosmetic dermatology consultations before or early in your GLP-1 journey to establish a baseline and develop a proactive treatment plan.
At Dermagnify, Dr. Cappel recommends that patients beginning GLP-1 therapy schedule a skin health consultation before significant weight loss occurs. Early intervention consistently yields better outcomes than waiting until facial changes are pronounced.
How to Fix Ozempic Face: Treatment Options at Dermagnify
There is no single treatment that addresses all aspects of Ozempic face. Because the condition involves both volume loss and skin laxity, the most effective approach is a personalized, multi-modality plan. Dr. Cappel evaluates each patient's degree of facial volume loss, skin quality, and aesthetic goals before recommending any combination of the following treatments.
At Dermagnify, Dr. Cappel favors natural, regenerative solutions over volume replacement alone. Rather than defaulting to fillers, the focus is on treatments that help the skin rebuild its own structural proteins and address laxity at the source - restoring a refreshed, natural appearance without overcorrecting.
1. Exion Face: Rebuilding Hyaluronic Acid Naturally
For patients experiencing the hollowness and skin deflation associated with Ozempic face, Exion Face offers a natural, non-injectable approach to restoring hydration and volume from within. Exion Face uses focused ultrasound energy combined with monopolar radiofrequency to stimulate the skin's own production of hyaluronic acid, collagen, and elastin - addressing the root cause of the deflated appearance rather than simply filling it in.
At Dermagnify, Dr. Cappel frequently recommends Exion Face as a first step for GLP-1 patients, particularly those who prefer to avoid injectables or who want to rebuild skin quality before considering any volumizing treatment.
2. Sofwave: Ultrasound Skin Tightening for GLP-1-Related Laxity
For patients experiencing skin laxity as a direct result of rapid fat loss during GLP-1 treatment, Sofwave addresses the structural component that develops when subcutaneous volume loss outpaces the skin's ability to contract.
Sofwave uses proprietary SUPERB ultrasound technology to deliver precise, parallel beams of energy to the mid-dermal layer, heating tissue to 65-70°C to stimulate the production of new collagen, elastin, and hyaluronic acid. Unlike fillers, which replace lost volume, Sofwave works by rebuilding the skin's structural foundation from within, making it particularly well suited for patients whose skin quality and firmness have declined alongside facial fat loss.
At Dermagnify, Dr. Cappel uses Sofwave as part of a natural, regenerative approach for GLP-1 patients, often in combination with Exion Face and Emface, to address laxity, firmness, and skin quality without relying on volume replacement. The treatment requires no downtime, is safe for all skin types, and delivers progressive results over 8 to 12 weeks following a single session. Learn more about Sofwave skin tightening at Dermagnify.
3. Emface: Non-Invasive Lift and Skin Remodeling
For patients who want to address skin laxity and facial muscle tone without needles, Emface is one of the most advanced non-surgical options available at Dermagnify.
Emface is the only device that simultaneously combines Synchronized RF (radiofrequency) and HIFES technology (High-Intensity Facial Electrical Stimulation). The RF component heats the dermis to stimulate collagen and elastin remodeling, while HIFES selectively contracts facial muscles to restore density and lift. Clinical studies show a 37% reduction in wrinkles, a 30% increase in muscle tone, and a 200% increase in elastin following a course of treatment.
For patients experiencing Ozempic face, Emface is particularly well-suited as a complement to Sofwave and Exion Face, addressing the muscular support component that energy-based skin treatments alone cannot correct.
4.Ellacor: Removing Excess Lax Skin
For patients with more pronounced skin laxity following significant weight loss on GLP-1 therapy, Ellacor offers something no energy device can: the actual removal of excess skin tissue. Ellacor is an FDA-cleared, micro-coring technology that physically removes small cores of lax skin without leaving visible scars, allowing the surrounding tissue to contract and tighten naturally.
At Dermagnify, Dr. Cappel uses Ellacor for patients whose skin laxity has progressed beyond what collagen stimulation alone can adequately address. It is particularly effective in the mid and lower face, where jowling and loose skin are most pronounced after GLP-1-related fat loss.
5. PRP and PRF Therapy: Regenerating Skin Quality From Within
Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) therapy harnesses the regenerative power of your own blood to stimulate collagen production and improve overall skin quality. At Dermagnify, these treatments are used to address the crepey texture, thinning, and dullness that often accompany Ozempic face. These are changes that fillers and energy devices may not fully resolve on their own.
PRF releases growth factors slowly over 7 to 10 days, providing more sustained regeneration than traditional PRP. Extensive clinical research demonstrates that 80% of studies report improvements in skin thickness and 75% in elasticity following PRP/PRF treatment, outcomes directly relevant to patients experiencing GLP-1-related skin changes.
PRP and PRF can be combined with microneedling for enhanced collagen penetration, or used alongside fillers as part of a comprehensive facial rejuvenation protocol.
6. Medical-Grade Skincare: Maintaining Results Long-Term
No treatment plan for Ozempic face is complete without a structured medical-grade skincare regimen to support collagen production, maintain skin integrity, and prolong the results of in-office treatments.
At Dermagnify, Dr. Cappel uses advanced skin analysis, including the Alma IQ imaging system, to identify subclinical skin changes invisible to the naked eye and formulates a personalized regimen from the practice's exclusive line of medical-grade products. Key actives for GLP-1 patients include prescription-strength retinoids, peptide complexes, and antioxidant serums that directly support the skin's natural collagen cycle.
7.Dermal Fillers: When Clinically Indicated
Dermagnify is not a filler-centric practice. Dr. Cappel's approach to Ozempic face prioritizes natural, regenerative treatments that help the skin rebuild its own structural proteins. However, for patients with significant volume loss that cannot be fully addressed through regenerative approaches alone, dermal fillers may be considered as part of a comprehensive treatment plan. This decision is made on a case-by-case basis during consultation, based on the patient's degree of facial deflation, skin quality, and overall aesthetic goals.
What to Expect: A Personalized Approach, Not a Template
Ozempic face is not a one-size-fits-all condition, and it does not benefit from a one-size-fits-all treatment approach. At Dermagnify in Ponte Vedra Beach, every patient begins with a comprehensive consultation with Dr. Mark A. Cappel, who evaluates the degree of volume loss, skin laxity, texture changes, and overall aesthetic goals.
Because Dr. Cappel is dual board-certified in both dermatology and dermatopathology, a distinction that allows him to correlate what he sees clinically with how the skin is functioning at a cellular level, his treatment recommendations are grounded in diagnostic precision. Patients across Northeast Florida come to Dermagnify from Jacksonville, St. Augustine, and the surrounding communities for exactly this level of clinical depth.
Ready to Restore Your Confidence?
If you are experiencing facial changes related to GLP-1 medication, you do not have to simply accept it. At Dermagnify in Ponte Vedra Beach, FL, Dr. Cappel and his team are here to help you navigate your options with precision, compassion, and clinical expertise.
100 Executive Way, Suite 114, Ponte Vedra Beach, FL 32082
Book your consultation at Dermagnify
Frequently Asked Questions About Ozempic Face
What exactly causes Ozempic face?
Ozempic face is caused by rapid loss of subcutaneous facial fat during GLP-1-assisted weight loss. As the fat compartments that give the face its youthful structure deflate faster than the skin can contract, hollowing, sagging, and skin laxity appear. The medication does not directly damage the skin. The change is a consequence of accelerated fat loss.
Is Ozempic face permanent?
Ozempic face is not permanent and can be effectively addressed with non-surgical treatments. Depending on the degree of volume loss and skin laxity, a personalized combination of Exion Face, Sofwave, Emface, Ellacor, and PRP/PRF therapy can restore a natural, refreshed appearance without surgery or significant downtime.
How soon after starting GLP-1 medication can Ozempic face appear?
Facial changes can begin to appear within the first several months of treatment, often becoming more noticeable after 10 to 15 percent of total body weight has been lost. The rate of weight loss plays a significant role. Patients who lose weight more gradually tend to experience less pronounced facial changes.
Do I have to stop taking Ozempic or Wegovy to treat Ozempic face?
No. You do not need to discontinue your GLP-1 medication to pursue aesthetic treatment. At Dermagnify, Dr. Cappel works with patients who are actively on GLP-1 therapy to develop a treatment plan that addresses facial changes while respecting their medical weight loss goals.
Is Sofwave effective for Ozempic face?
Yes. Sofwave targets the skin laxity that often accompanies rapid fat loss during GLP-1 treatment. By stimulating collagen, elastin, and hyaluronic acid production in the mid-dermis, Sofwave helps rebuild the skin's structural foundation from within. At Dermagnify, Dr. Cappel frequently combines Sofwave with Exion Face and Emface as part of a natural, regenerative plan for patients experiencing GLP-1-related facial changes.
How many treatments will I need to fix Ozempic face?
This varies significantly by patient. Some individuals achieve excellent results after a single session of Exion Face or Sofwave. Others benefit from a phased approach combining multiple regenerative treatments over several months, particularly if they are continuing to lose weight. Dr. Cappel will outline a realistic timeline during your consultation at our Ponte Vedra Beach clinic.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult with a qualified healthcare provider before beginning any new treatment. Individual results may vary.